Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLF - Get Free Report) shares hit a new 52-week low during mid-day trading on Thursday . The company traded as low as $9.23 and last traded at $9.23, with a volume of 100 shares changing hands. The stock had previously closed at $10.99.
Ono Pharmaceutical Trading Down 16.0 %
The stock has a market cap of $4.75 billion, a price-to-earnings ratio of 6.89 and a beta of 0.56. The company's fifty day moving average is $12.69 and its two-hundred day moving average is $13.60.
Ono Pharmaceutical Company Profile
(
Get Free Report)
Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.
Further Reading
Before you consider Ono Pharmaceutical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ono Pharmaceutical wasn't on the list.
While Ono Pharmaceutical currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
